ALX Oncology Holdings Inc.
ALXO
$1.93
-$0.08-3.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -21.08% | -23.96% | -8.60% | 1.20% | -0.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.12% | -35.55% | -29.21% | -32.17% | -34.39% |
| Operating Income | 30.12% | 35.55% | 29.21% | 32.17% | 34.39% |
| Income Before Tax | 30.61% | 31.65% | 24.59% | 28.55% | 32.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.61% | 31.65% | 24.59% | 28.55% | 32.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.61% | 31.65% | 24.59% | 28.55% | 32.00% |
| EBIT | 30.12% | 35.55% | 29.21% | 32.17% | 34.39% |
| EBITDA | 30.18% | 36.00% | 29.65% | 32.62% | 34.84% |
| EPS Basic | 48.20% | 39.67% | 27.21% | 31.98% | 39.60% |
| Normalized Basic EPS | 47.07% | 42.07% | 29.50% | 33.98% | 41.24% |
| EPS Diluted | 48.20% | 39.67% | 27.21% | 31.98% | 39.60% |
| Normalized Diluted EPS | 47.07% | 42.07% | 29.50% | 33.98% | 41.24% |
| Average Basic Shares Outstanding | 63.95% | 26.20% | 3.48% | 4.69% | 10.52% |
| Average Diluted Shares Outstanding | 63.95% | 26.20% | 3.48% | 4.69% | 10.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |